Health knowledge made personal
Join this community!
› Share page:
Search posts:

FDA approves Afinitor (everolimus) for treatment of metastatic breast cancer

Posted Jul 20 2012 10:00pm

The US Food and Drug Administration (FDA) has approved the much awaited Afinitor® (everolimus) from Novartis that was part of the successful  BOLERO2 study. Based on the positive results of the study, we have all been waiting for the approval of this new drug to the tool kit for advanced breast cancer.

5 6 7 8
© 2004–2012 Donna Peach. All rights reserved.
Post a comment
Write a comment: